Breast Cancer | Specialty

The OncLive Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Dr. Vogelzang Describes Cabozantinib's Side Effects

June 21st 2011

Dr. Nicholas Vogelzang from the Comprehensive Cancer Centers of Nevada Describes Cabozantinib's side effects

Chemotherapy Improves Survival in Older Women With Advanced ER-Negative Breast Cancer

June 21st 2011

Older women with estrogen receptor (ER)-negative metastatic breast cancer have a 39% lower risk of all-cause mortality if they receive chemotherapy within 6 months of their diagnosis.

Cost-Effectiveness of 70-Gene MammaPrint Signature in Node-Negative Breast Cancer

June 21st 2011

Breast cancers with similar clinicopathologic characteristics may have strikingly different outcomes.

Dr. Vogelzang on Cabozantinib Clinical Trial Results

June 20th 2011

Dr. Nicholas J. Vogelzang from the Comprehensive Cancer Centers of Nevada on Cabozantinib Clinical Trial Results

Adjuvant chemotherapy in breast cancer: An expiration date?

June 20th 2011

One issue that confronts medical oncologists is the explanation of benefits from chemotherapy

New Genetic Test Aids Detection of HER2+ Breast Cancer

June 15th 2011

On Tuesday the FDA approved a genetic test known as Inform Dual ISH that detects HER2+ breast cancer

Disease States: Breast Cancer

June 13th 2011

Breast cancer resources gathered from across the web including a news brief, patient education, clinical trials and CME/CE

Searching for Sharper Images in Breast Screenings

June 13th 2011

Breast imaging technology has evolved in recent years, and although the mammogram remains the gold standard for screening, researchers are excited about the possibilities of molecular breast imaging

Latinas More Likely to Worry About Breast Cancer Recurrence

June 9th 2011

Investigators have documented a wide variation in the extent to which women with early-stage breast cancer worry about the possibility of recurrent disease

Post-Oophorectomy Hormone Replacement Therapy Safe for BRCA1/2 Mutation Carriers

June 7th 2011

Women who present with BRCA1 and BRCA2 mutation face an increased risk of breast and ovarian cancer.

PTEN Expression Does Not Diminish Trastuzumab Effectiveness

June 7th 2011

Phosphatase and tensin homolog (PTEN)-positive breast cancer can be treated with trastuzumab (Herceptin) as effectively as PTEN-negative breast cancer

Deciphering the Challenge of the Genomic Era in Breast Cancer

June 6th 2011

Luminal A genetic signature in node-negative, estrogen receptor- (ER-) positive breast cancer predicts a very high disease-free survival rate

Rethinking Initial Management of Patients With Brain Metastasis and HER2 Breast Cancer

June 6th 2011

Lapatinib and capecitabine is a reasonable approach in a well-informed patient with brain metastasis and HER2+ breast cancer

NKTR-102 Shows Promise in Phase II Trial

June 5th 2011

Metastatic breast cancer patients with demonstrated disease progression after taxane therapy face an uphill battle in fighting their disease.

Regional Radiation Therapy Improves Outcomes in Early Breast Cancer

June 5th 2011

Radiation therapy directed to the regional lymph nodes of women with early-stage breast cancer reduced distant disease recurrence

Attacking the Frontiers of Breast Cancer: A Conversation With Joyce A. O'Shaughnessy, MD

June 3rd 2011

As a child Joyce Ann O'Shaughnessy enjoyed science and her home chemistry set. Still, she didn't give much thought to pursuing the subject beyond the confines of her school - until she faced a tragedy.

NCCN's 16th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care

May 24th 2011

Each year the National Comprehensive Cancer Network (NCCN) presents the latest updates to its Clinical Practice Guidelines in Oncology, as well as the latest cancer therapies by key opinion leaders.

OncLive Nursing FDA Updates From April 2011

May 21st 2011

3D mammogram system approved, NCCN 2011 Avastin breast cancer guidelines, and the approval of generic docetaxel.

ASCO Updates Guidelines on Bone-Modifying Drugs in Breast Cancer

May 20th 2011

ASCO releases new recommendations amid growing therapeutic options and fresh concerns about serious skeletal-related events.

Among Women at High Risk for Breast Cancer, Study Finds Smoking, Not Moderate Alcohol Use, Increases Risk of Common Cancers

May 18th 2011

A prospective study analyzed the risk of contracting common cancers based on baseline self-reporting data on smoking, alcohol use, and physical activity